Daniel Virnich is Chief Executive Officer of Oncology Institute, Inc.. Currently has a direct ownership of 1.79 Million shares of TOI, which is worth approximately $4.58 Million. The most recent transaction as insider was on May 21, 2025, when has been sold 20,388 shares (Common Stock) at a price of $2.67 per share, resulting in proceeds of $54,435. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.79M
1.13% 3M change
148.78% 12M change
Total Value Held $4.58 Million

Daniel Virnich Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2025
SELL
Sale (or disposition) back to the issuer
$54,435 $2.67 p/Share
20,388 Reduced 1.13%
1,787,309 Common Stock
Mar 31 2025
BUY
Grant, award, or other acquisition
-
1,083,334 Added 37.47%
1,807,697 Common Stock
Mar 26 2025
BUY
Open market or private purchase
$23,545 $1.04 p/Share
22,640 Added 3.03%
724,363 Common Stock
Mar 19 2025
SELL
Sale (or disposition) back to the issuer
$9,132 $0.89 p/Share
10,261 Reduced 1.44%
701,723 Common Stock
Nov 20 2024
SELL
Sale (or disposition) back to the issuer
$1,361 $0.14 p/Share
9,727 Reduced 1.35%
711,984 Common Stock
Nov 12 2024
SELL
Other acquisition or disposition
-
195,236 Reduced 21.29%
721,711 Common Stock
May 21 2024
SELL
Sale (or disposition) back to the issuer
$6,703 $0.6 p/Share
11,173 Reduced 1.53%
718,430 Common Stock
May 21 2024
BUY
Grant, award, or other acquisition
-
198,517 Added 17.8%
916,947 Common Stock
Nov 21 2023
SELL
Sale (or disposition) back to the issuer
$9,465 $2.19 p/Share
4,322 Reduced 0.59%
729,603 Common Stock
Nov 14 2023
SELL
Sale (or disposition) back to the issuer
$10,957 $2.38 p/Share
4,604 Reduced 0.62%
733,925 Common Stock
Mar 17 2023
BUY
Grant, award, or other acquisition
-
114,944 Added 13.47%
738,529 Common Stock
Dec 07 2022
BUY
Exercise of conversion of derivative security
$301,000 $0.86 p/Share
350,000 Added 35.95%
623,585 Common Stock
Nov 17 2022
BUY
Grant, award, or other acquisition
-
40,101 Added 12.78%
273,585 Common Stock
Nov 15 2022
SELL
Sale (or disposition) back to the issuer
$7,647 $2.03 p/Share
3,767 Reduced 1.59%
233,484 Common Stock
Mar 21 2022
BUY
Grant, award, or other acquisition
-
42,015 Added 15.04%
237,251 Common Stock
Nov 12 2021
BUY
Grant, award, or other acquisition
-
195,236 Added 50.0%
195,236 Common Stock
DV

Daniel Virnich

Chief Executive Officer
Cerritos, CA

Track Institutional and Insider Activities on TOI

Follow Oncology Institute, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TOI shares.

Notify only if

Insider Trading

Get notified when an Oncology Institute, Inc. insider buys or sells TOI shares.

Notify only if

News

Receive news related to Oncology Institute, Inc.

Track Activities on TOI